Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Atkin

Showing results (11-20 of 128) with videos related to

Pageof 13
Sort By:
Seminars in Fetal & Neonatal Medicine|October 31, 2009
Obesity and gestational diabetesT Sathyapalan, D Mellor, S L Atkin
Annals of Clinical Biochemistry|April 11, 2014
LDL cholesterol variability in patients with Type 2 diabetes taking atorvastatin and simvastatin: a comparison of two formulae for LDL-C estimationT Sathyapalan, S L Atkin, E S Kilpatrick
Diabetes, Obesity & Metabolism|August 4, 2004
Nateglinide alone or with metformin safely improves glycaemia to target in patients up to an age of 84J U Weaver, D Robertson, S L Atkin
BMJ (Clinical Research Ed.)|June 18, 2011
Postural hypotensionT Sathyapalan, M M Aye, S L Atkin
The Journal of Steroid Biochemistry and Molecular Biology|January 8, 1999
Activity and gene expression of 17beta-hydroxysteroid dehydrogenase type I in primary cultures of epithelial and stromal cells derived from normal and tumourous human breast tissue: the role of IL-8V Speirs, A R Green, S L Atkin
Diabetic Medicine : a Journal of the British Diabetic Association|February 19, 2005
Improvement of glycaemic control with rebound following orlistat initiation and cessation associated with minimal weight changeS González, E S Kilpatrick, S L Atkin
Diabetes, Obesity & Metabolism|June 4, 2010
Low density lipoprotein-cholesterol variability in patients with type 2 diabetes taking atorvastatin compared to simvastatin: justification for direct measurement?T Sathyapalan, S L Atkin, E S Kilpatrick
Diabetic Medicine : a Journal of the British Diabetic Association|October 31, 2008
Variability of lipids in patients with Type 2 diabetes taking statin treatment: implications for target settingT Sathyapalan, S L Atkin, E S Kilpatrick
In Vitro Cellular & Developmental Biology. Animal|July 1, 1996
An in vitro model of diabetesS L Atkin, E A Masson, D Wilcox
BMJ (Clinical Research Ed.)|June 18, 2010
A persistent headacheA J Dawson, C Rowland-Hill, S L Atkin
Pageof 13

Showing results (11-20 of 128) with videos related to

Sort By:
Pageof 13
Seminars in Fetal & Neonatal Medicine|October 31, 2009
Obesity and gestational diabetesT Sathyapalan, D Mellor, S L Atkin
Annals of Clinical Biochemistry|April 11, 2014
LDL cholesterol variability in patients with Type 2 diabetes taking atorvastatin and simvastatin: a comparison of two formulae for LDL-C estimationT Sathyapalan, S L Atkin, E S Kilpatrick
Diabetes, Obesity & Metabolism|August 4, 2004
Nateglinide alone or with metformin safely improves glycaemia to target in patients up to an age of 84J U Weaver, D Robertson, S L Atkin
BMJ (Clinical Research Ed.)|June 18, 2011
Postural hypotensionT Sathyapalan, M M Aye, S L Atkin
The Journal of Steroid Biochemistry and Molecular Biology|January 8, 1999
Activity and gene expression of 17beta-hydroxysteroid dehydrogenase type I in primary cultures of epithelial and stromal cells derived from normal and tumourous human breast tissue: the role of IL-8V Speirs, A R Green, S L Atkin
Diabetic Medicine : a Journal of the British Diabetic Association|February 19, 2005
Improvement of glycaemic control with rebound following orlistat initiation and cessation associated with minimal weight changeS González, E S Kilpatrick, S L Atkin
Diabetes, Obesity & Metabolism|June 4, 2010
Low density lipoprotein-cholesterol variability in patients with type 2 diabetes taking atorvastatin compared to simvastatin: justification for direct measurement?T Sathyapalan, S L Atkin, E S Kilpatrick
Diabetic Medicine : a Journal of the British Diabetic Association|October 31, 2008
Variability of lipids in patients with Type 2 diabetes taking statin treatment: implications for target settingT Sathyapalan, S L Atkin, E S Kilpatrick
In Vitro Cellular & Developmental Biology. Animal|July 1, 1996
An in vitro model of diabetesS L Atkin, E A Masson, D Wilcox
BMJ (Clinical Research Ed.)|June 18, 2010
A persistent headacheA J Dawson, C Rowland-Hill, S L Atkin
Pageof 13